Combo Product Dispute Resolution, Primary Mode Of Action Detailed By OCP

Combination products without regulatory precedent will be assigned to the FDA center with the most expertise in evaluating the products' primary safety and efficacy concerns, according to a proposed rule published in the May 7 Federal Register